Health, Fitness & Food

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer’s. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 drugs, wants to make big bets.  These are the ideas that are “hiding in plain sight,” said Lilly Chief Scientific Officer

Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol.  That’s according to new government-funded research

In this article HIMS Follow your favorite stocksCREATE FREE ACCOUNT Hims & Hers Health announced Wednesday it has acquired New Jersey-based at-home lab testing facility Trybe Labs. The deal will allow the telehealth company to offer at-home blood draws and more comprehensive pre-treatment testing to its users. “Access to richer data allows us to deepen

In this article CVS BLUE VRTX Follow your favorite stocksCREATE FREE ACCOUNT Starting in his early teens, Deshawn “DJ” Chow wasn’t sure he’d ever be able to live a normal life. Crushing pain episodes brought on by his sickle cell disease were getting progressively worse.    “It’s just been hard skipping school and always being

Innovaccer CEO Abhinav Shashank. Courtesy: Innovaccer As doctors and nurses face historic rates of burnout, Innovacer says artificial intelligence is here to help. The health-care data company on Monday announced a suite of AI agents that are designed to automate repetitive, “low-value” tasks for clinicians.  “We just don’t have enough capacity in the health system to

In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its

Paradromics’ Connexus Brain-Computer Interface. Courtesy: Paradromics Texas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia’s Neom and said it will establish a Brain-Computer Interface Center of Excellence in the region. Neom is a developing area within northwest Saudi Arabia that’s touted as “a hub for innovation,” according to its website. The

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s

A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than Merck‘s Keytruda in a clinical trial. The company, Summit Therapeutics, licensed the drug from Chinese company Akeso Inc.  In October, a group of life science investors announced they were putting $400

Things continue to look up for GE Healthcare stock this year. Shares of the medical technology company jumped roughly 9% on Thursday after delivering solid fourth-quarter results and providing prudent 2025 guidance. While the Club stock left much to be desired in 2024, these numbers boosted shares that were already bouncing off their most recent

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images After a dismal 2024, CVS Health could be starting to turn itself around.  Some

Prenuvo’s clinic in New York City, New York. Courtesy of Prenuvo Preventative health startup Prenuvo on Thursday announced it will offer three new health assessments in addition to its flagship full-body MRI scan. The company is launching a detailed blood test, neurological scan and body composition analysis that was approved by the U.S. Food and

Biotech researchers. Janiecbros | E+ | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Trump administration is trying to implement major funding cuts to the National Institutes of Health that would cap

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Apple CEO Tim Cook delivers remarks before the start of an Apple event at the Apple headquarters in Cupertino, California, on Sept. 9, 2024. Justin Sullivan | Getty Images Apple is deepening its investment in health-care research by launching a new, years-long project called the

We are buying 300 shares of Bristol Myers Squibb at roughly $55.44. In addition, we are selling 100 shares Starbucks at roughly $111.48. Following the trades, Jim Cramer’s Charitable Trust will own 1,800 shares of BMY, increasing its weighting to about 2.7% from about 2.25% and 1,000 shares of SBUX, decreasing its weighting to about

President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC. Oliver Contreras | Afp | Getty Images President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company’s quarterly earnings topped Wall Street estimates, but sales fell just short as Mounjaro saw lower realized prices.

In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday said it will slash $2 billion in costs by the end of 2027, expanding its